Boston Scientific Corp (BSX)

Debt-to-capital ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	19,282,000	18,886,000	18,226,000	17,850,000	17,573,000	17,640,000	17,251,000	16,735,000	16,623,000	16,461,000	15,942,000	15,720,000	15,327,000	15,564,000	15,616,000	13,804,000	13,877,000	9,698,000	9,424,000	9,232,000
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $19,282,000K)
= 0.00

The debt-to-capital ratio of Boston Scientific Corp. has been relatively stable over the past eight quarters, ranging from 0.32 to 0.36. This ratio indicates the proportion of the company's capital structure that is financed by debt, with values above 0.5 typically suggesting a higher level of financial leverage.

A decreasing trend in the debt-to-capital ratio over time may indicate that the company is reducing its reliance on debt for financing its operations. Conversely, an increasing trend could signal a higher risk level due to increased debt obligations.

In the case of Boston Scientific Corp., the ratio has hovered around the 0.32 to 0.36 range, indicating a moderate level of debt financing within the company's capital structure. It is essential for investors and analysts to monitor this ratio over time to assess the company's financial health and risk profile, taking into account industry benchmarks and the company's specific circumstances.